Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia

Biological Psychiatry

Volumn 48, Issue 12, 2000, Pages 1121-1132

  Walder, Deborah J ^a   Walker, Elaine F ^a   Lewine, Richard J ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive; Cortisol; Hippocampus; Memory; Schizophrenia; Symptoms

Indexed keywords

HYDROCORTISONE;

AMNESIA; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SALIVA ANALYSIS; SCHIZOIDISM; SCHIZOPHRENIA; SCORING SYSTEM; TASK PERFORMANCE;

ADULT; CASE-CONTROL STUDIES; COGNITION; DEPRESSIVE DISORDER; FEMALE; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MEMORY; MIDDLE AGED; MODELS, PSYCHOLOGICAL; NEUROPSYCHOLOGICAL TESTS; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SALIVA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0034672197     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01052-0     Document Type: Article

References (77)

1. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development
2. Cortisol concentrations in serum of borderline hypertensive men exposed to a novel experimental setting
3. The hippocampus and parahippocampus in schizophrenic, suicide, and control brains
4. Symptoms of schizophrenia: Methods, meanings, and mechanisms
5. The dexamethasone suppression test in psychotic disorders
6. The physiological measurement of acute stress in bank employees
7. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia
8. Measurement of stress hormones
9. Morphometric analyses of the hippocampal formation in schizophrenic brain
10. Anterior hippocampal volume reductions predict "frontal lobe" dysfunction in first episode schizophrenia
11. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection
12. Basal ganglia and limbic system pathology in schizophrenia
13. Brain morphology and schizophrenia: A magnet resonance imaging study of limbic prefrontal cortex and caudate structures
14. An adaptive-rate continuous performance test: Vigilance characteristics and reliability for 400 male students
15. Adrenal cortical activity in depressive illness
16. Raised plasma cortisol concentrations are a feature of drug-free psychotics and are not specific for depression
17. Memory functions and temporal-limbic morphology in schizophrenia
18. Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study
19. Acute cortisone administration impairs retrieval of long-term declarative memory in humans
20. Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: A re-evaluation study
21. Functional organization of the hippocampal memory system
22. Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST
23. Forms of memory failure in schizophrenia
24. The performance of patients with schizophrenia on the Wechsler Memory Scale-Revised
25. Neuropsychological assessment of monozygotic twins discordant for schizophrenia
26. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia
27. A case against subtyping in schizophrenia
28. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression
29. Endocrine sensitivity to novelty in squirrel monkeys and titi monkeys: Species differences in characteristic modes of responding to the environment
30. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects
31. Neuropsychological functioning of first-episode schizophreniform patients
32. Hippocampal pathologic findings in schizophrenia. A morphometric study
33. Hypothalamic pituitary adrenal axis function in chronic schizophrenia: Association with clinical features
34. DST and schizophrenic symptomatology
35. Salivary cortisol levels throughout childhood and adolescence: Relation with age, pubertal stage and weight
36. Salivary cortisol in psychobiological research: An overview
37. Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults
38. A neurohistological correlate of schizophrenia
39. Salivary cortisol measurement: A practical approach to assess pituitary-adrenal function
40. Quantitative magnetic resonance imaging in temporal lobe epilepsy: Relationship to neuropathology and neuropsychological function
41. Basal cortisol levels and cognitive deficits in human aging
42. Stress-induced declarative memory impairment in healthy elderly subjects: Relationship to cortisol reactivity
43. The application of signal detection theory to letter recognition
44. A modified card sort test sensitive to frontal lobe defects
45. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia
46. Glucocorticoid interactions with memory function in schizophrenia
47. Glucocorticoid-induced impairment in declarative memory performance in adult humans
48. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients
49. Decreased memory performance in healthy humans induced by stress-level cortisol treatment
50. Neuroanatomical changes and hypothalamic-pituitary-adrenal axis abnormalities
51. Dexamethasone suppression test and the positive and negative symptoms of schizophrenia
52. Stress, glucocorticoids, and their role in degenerative changes in the aging hippocampus
53. Hippocampal damage associated with prolonged glucocorticoid exposure in primates
54. Neuropsychological deficits in neuroleptic naïve patients with first-episode schizophrenia
55. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression
56. A corticosteroid/dopamine hypothesis for psychotic depression and related states
57. Procedural learning of cognitive and motor skills in psychotic patients
58. Diurnal variation of plasma corticosterone in depression
59. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging
60. The effect of diagnosis and age on the DST: A meta-analytic approach
61. Utility of an oral diffusion sink (ODS) device for quantification of saliva corticosteroids in human subjects
62. Memory and the hippocampus. A synthesis from findings with rats, monkeys, and humans
63. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome
64. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia
65. A deficit profile of executive, memory and motor functions in schizophrenia
66. Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome
67. Lack of an association between delayed memory and hippocampal and temporal lobe size in patients with schizophrenia and healthy controls
68. Hippocampal volume in first-episode psychoses and chronic schizophrenia: A high-resolution magnetic resonance imaging study
69. Auditory sensory gating, hippocampal volume, and catecholamine metaboism in schizophrenics and their siblings
70. Schizophrenia: A neural diathesis-stress model
71. Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder